| Dr Glenn Lee Lawrence, MD | |
|
1700 University Dr E, College Station, TX 77840-2661 | |
| (409) 691-3300 | |
| Not Available |
| Full Name | Dr Glenn Lee Lawrence |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1700 University Dr E, College Station, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073574216 | NPI | - | NPPES |
| 81X065 | Other | TX | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | J7807 (Texas) | Primary |
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.
The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.
Contradicting long-standing conventional wisdom, results of a Johns Hopkins-led analysis of data previously gathered on more than 3,000 family caregivers suggests that those who assist a chronically ill or disabled family member enjoy an 18 percent survival advantage compared to statistically matched non-caregivers.
Developments in nanotechnology and nanorobotics are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales. While nanomedicine promises a new exciting frontier for clinical practice and biomedical research, issues involving cost-effectiveness studies, clinical trials and toxicity assays, drug delivery methods, and the implementation of new personalized therapies still remain challenging.
Scientists in Sydney, Australia, have discovered that obesity and type 2 diabetes in pregnancy can program children to develop metabolic problems later in life. The good news is, this legacy is not set in stone-if children of obese mothers are careful about what they eat, it can be overturned.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn Lee Lawrence, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-2111 | Dr Glenn Lee Lawrence, MD 1700 University Dr E, College Station, TX 77840-2661 Ph: (409) 691-3300 |
News Archive
Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.
The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.
Contradicting long-standing conventional wisdom, results of a Johns Hopkins-led analysis of data previously gathered on more than 3,000 family caregivers suggests that those who assist a chronically ill or disabled family member enjoy an 18 percent survival advantage compared to statistically matched non-caregivers.
Developments in nanotechnology and nanorobotics are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales. While nanomedicine promises a new exciting frontier for clinical practice and biomedical research, issues involving cost-effectiveness studies, clinical trials and toxicity assays, drug delivery methods, and the implementation of new personalized therapies still remain challenging.
Scientists in Sydney, Australia, have discovered that obesity and type 2 diabetes in pregnancy can program children to develop metabolic problems later in life. The good news is, this legacy is not set in stone-if children of obese mothers are careful about what they eat, it can be overturned.
› Verified 2 days ago
Kenneth E Matthews, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1602 Rock Prairie Rd, Suite 340, College Station, TX 77845 Phone: 979-696-4440 Fax: 979-694-8500 | |
Neal Moreau Spears, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4401 Highway 6 S, College Station, TX 77845 Phone: 979-690-4480 Fax: 979-690-4481 | |
Patricia Whitehead Goen, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1651 Rock Prairie Rd, #102, College Station, TX 77845 Phone: 979-693-7400 Fax: 979-693-7446 | |
Scott T Schams, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1602 Rock Prairie Rd, Suite 340, College Station, TX 77845 Phone: 979-696-4440 Fax: 979-694-8500 | |
Dr. Dayne M. Foster, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1700 University Dr E, College Station, TX 77840 Phone: 409-691-3300 | |
Dr. Daniel Grier Ransom, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000 Fax: 979-207-4562 |